Highlights
-
•
Secondary metabolites are used in pharmaceutical industries, cosmetics, dietary supplements, fragrances, flavors, dyes, etc.
-
•
Metabolic engineering is an important biological tool to produce commercially importance metabolites.
-
•
The biosynthetic pathways for production of secondary metabolites in plants are derived from the shikimate, terpenoid, and polyketide pathways.
-
•
A huge number of medicinal plants and their metabolites have been produced by in vitro techniques.
Keywords: Secondary metabolites, Bioactive compounds, Nanoparticles, Micropropagation, Phytochemicals
Abstract
Plants have been used throughout the world for its medicinal powers since ancient time. The pharmacological properties of plants are based on their phytochemical components especially the secondary metabolites which are outstanding sources of value added bioactive compounds. Secondary metabolites have complex chemical composition and are produced in response to various forms of stress to perform different physiological tasks in plants. They are used in pharmaceutical industries, cosmetics, dietary supplements, fragrances, flavors, dyes, etc. Extended use of these metabolites in various industrial sectors has initiated a need to focus research on increasing the production by employing plant tissue culture (PTC) techniques and optimizing their large scale production using bioreactors. PTC techniques being independent of climatic and geographical conditions will provide an incessant, sustainable, economical and viable production of secondary metabolites. This review article intends to assess the advantages of using plant tissue culture, distribution of important secondary metabolites in plant families, strategies involved for optimal metabolite production and the industrial importance of selected secondary metabolites.
1. Introduction
Plants have always played prominent roles in traditional as well as modern medicines. Almost 80% of the world's population relies on plant derived components for their crucial health and wellness [1,2]. They are rich in phytochemicals which have the miraculous capability to cure diseases and may be used in numerous sectors such as pharmaceuticals, cosmetics, nutraceuticals, etc. [3]. They are gaining more attention among the growing population because of their affordability, accessibility, eco-friendly and promising efficacy comparable to high cost synthetic drug agents. Thus, the preliminary attention of research till date on medicinal plants has been focused in the areas of pharmacognosy, phytochemistry and horticulture. The increasing demand for such products has sparked the need to find strategies to enhance their production without disturbing their natural population [4].
Plants are regarded as safe to humans. They are used to treat and prevent specific ailments and diseases in humans since time immemorial. Thus, plants which possess therapeutic metabolites with beneficial pharmacological effects are called medicinal plants [5]. The medicinal properties of these plants are because of the existence of the heterogeneous group of natural metabolic products called secondary metabolites which are divergent in their structure and metabolic pathways. These metabolites are not essential for the growth and development of plants [6] but they play many important roles as signalling molecules and as defense agents [7]. They are regarded as economically important products as they are used in drugs, flavors, fragrances, insecticides, dyes, etc. [8]. India is a reservoir of numerous high-valued medicinal plants and is one of the major medicinal plants producing Asian country.
They are produced by diverting energy-generating routes in metabolic pathways like photosynthesis, glycolysis, Krebs cycle to biosynthetic intermediates. They are classified in different categories based on their biosynthesis, structures and functions. They are biosynthesized from acetyl coenzyme A, mevalonic acid, shikimic acid, deoxyxylulose 5-phosphate or combined pathways [9]. They are classified as terpenoids, steroids, alkaloids, saponin, terpenes, lipids and enzyme cofactors [10,11]. The different classes of secondary metabolites produced by in vitro callus and cell suspension cultures have been tabulated in Table 1.
Table 1.
S. No. | Alkaloids | Terpenoids | Steroids | Quinones | Phenylpropanoids |
---|---|---|---|---|---|
1. | Acridines | Artemisinin | Brassinolide | Aloe-emodin | Anthocyanins |
2. | Betalaines | Cucurbitacins | Bufadienolides | Anthraquinones | Caffeic acid |
3. | Furoquinolines | Diterpenes | Catasterone | Benzoquinones | Coumarins |
4. | Galanthamine | Ginsenosides | Digoxin | Chrysophanol | Eugenol |
5. | Harringtonines Isoquinolines |
Meroterpenes | Digitoxin | Emodin | Ferulic acid |
6. | Lobeline | Monoterpenes | Digitoxigenin | β-Lapachol | Flavonoids |
7. | Quinolizidines | Paclitaxel | Ecdysteroids | Naphthoquinones | Hydroxycinnamoyl derivatives |
8. | Indole alkaloids |
Sesquiterpenes | Helleborin | Phenanthrenequinone | Isoflavonoids |
9. | Isoquinoline alkaloids |
Sesterpenes | Physodine | Plumbagin | Lignans |
10. | Piperidine | Thapsigargin | Ouabain | Rhein | Phenalinones |
11. | Thebaine | Triterpenes | Scillaridine | Shikonin | Proanthocyanidins |
12. | Trigonelline | Ursane triterpenoid | Steroidal glycosides | Thymoquinone | Stilbenes |
13. | Tropane alkaloids | Withanolides | Steroidal lactones | Uglone | Tannins |
Plant tissue culture (PTC) due to its various benefits has been used as a major platform for secondary metabolites production [12,13]. Thus, the review article aims to focus the merits of using PTC techniques for secondary metabolites production as well as the distribution of different classes of plant secondary metabolites in plant families, important medicinal uses and strategies to improve their production to increase yield. Few important medicinal plants along with their secondary metabolites of commercial importance have been summarized in Table 2.
Table 2.
S. No. | Plant Name | Active Metabolite(s) | Application(s) |
---|---|---|---|
1. | Catharanthus roseus | Indole alkaloids, catharanthine | Cancer therapy |
2. | Dioscorea doryphora | Diosgenin | Cancer therapy, hypercholesterolemia, Inflammation |
3. | Ruta species | Quinolone alkaloids, furanocoumarins, acridone, flavonoids | Natural fungicides and pesticide, contraceptive preparations, anti-inflammatory, antipyretic, antioxidant, analgesic, antiviral, antiplasmodial |
4. | Ginkgo biloba | Kaempferol, isorhamnetin, quercetin, bilobalide, ginkgolide A, B, C, ginsenoside | Anti-inflammatory, antidiabetes, cardiovascular diseases, cancer therapy |
5. | Arnebia euchroma | Shikonin | Antimicrobial, anticancer, antipyretic, anti-inflammatory |
6. | Carthamus tinctorius | Phenolics, flavonoids, alkaloids, lignans, carboxylic acids, steroids, polysaccharides, quinochalcone C-glycosides, quinone-containing chalcones | Gynecological diseases, cardiovascular diseases, cerebrovascular diseases anticoagulant, gastrointestinal, antioxidant, hypolipidemic |
7. | Datura stramonium | Tropane alkaloids (hyoscyamine, atropine and scopolamine) | Relive pain of rheumatism and gout, hallucinogenic drug, treat epilepsy and depression, powerful mind altering drug, anti-inflammatory, antimicrobial |
8. | Ephedra | Ephedrine alkaloids (1-ephedrine, d-pseudoephedrine, norephedrine, norpseudoephedrine, methylephedrine and methylpseudoephedrin), Flavonoids (eucodelphinidin, leucopelargonine, leucoanthocyanidin, lucenine, vicenin-1 and vicenin-2), proanthocyanidines | Appetite suppression, psychostimulant, prophylaxis of asthma, nasal congestion and hypotension caused by spinal anesthesia and urinary incontinence |
9. | Rauwolfia species | Ajmaline, ajmalicine, solasodine, α-solanine, serpentine and reserpine, β-carboline, alstonine, rescinnamine, reserpiline | Natural tranquilizer, hypertension, insomnia, epilepsy, schizophrenia, antidote against snake bite |
10. | Vitis vinifera | Stilbene, procyanidins, resveratrol, anthocyanins, quercetin, myricetin, laricitrin, kaempferol, syringetin, isorhamnetin, epicatechin, flavonols, vineferin | Laxative, purgative, diuretic, antioxidative, anti-inflammatory, antithrombotic, neuroprotective agents, antianxietic, anticancer agents |
11. | Taxus species | Paclitaxel, essential oils, flavonoids, taxol, baccatin III, lignans | Treatment of rheumatism, aphrodisiac, epilepsy, antidote for snake bite, antiepileptic, anti-inflammatory, anticancer, antipyretic, analgesic, immunomodulatory, antimicrobial activities. |
12. | Scopolia parviflora | Scopalamine, hyoscyamine | Anticholinergic drug, antispasmodic drug hallucinogenic agent, treat motion sickness |
13. | Rubia tinctorum | Tropane alkaloids, phytosterols, saponins, tannins, phenolic compounds, anthraquinone glycosides, triterpenoids | Treatment of skin disease, spleen disorders, astringent, febrifuge, hepatoprotective agent, antithrombotic, antioxidants |
14. | Coleus blumei | Rosmarinic acid, β-sitosterol, forskolin, apigenin, chavicol, cavacrol, eugenol, quercetin | Anticancer, antidepressant, antigalucomic, antimetastastic, cardiotonic, nervous system depressant, vasodialator, immunosuppressant, antioxidant |
15. | Saussurea medusa | Sesquiterpenoids flavonoids, phytosterols, triterpenoids, lignans, phenolics, gallic acid, syringin, chlorogenic acid, ethyl gallat, rutin, isoquercitrin | Anti-inflammatory, anticancer, antitumor, hepatoprotective, anti-ulcer, cholagogic, immunosuppressive, spasmolytic, antimicrobial, CNS depressant, antioxidant |
16. | Trichosanthes, Cucurbita, Cucumis and Citrullus | Cucurbitacins | Anti-inflammatory, anti-diabetic activity, anti-tumor, anti-artherosclerotic activity |
17. | Dryopteris filix-mas | Phloroglucinols like aspidin, deaspidin, filixic acid | Anti-inflammatory, treating rheumatoid arthritis, wounds, ulcers |
18. | Thymus species | Borneol, α-terpineol, carvacrol, thymol, geraniol, carotenoids, rosmarinic acid | Anti-inflammatory, hepatoprotective, antimicrobial, anti-HIV-1 activity, antiulcer, gastroprotective, hypoglycemic, antihyperlipidemic activity, antioxidative capacity, flavouring agent |
19. | Punica granatum | Pelletierine, ellagic acid, phenol, flavonoid | Anti-cancer, cardiovascular disease, anti-diabetes, treat dental problems immune modulatory activity |
20. | Stevia rebaudiana | Stevioside, steviol rebaudioside, essential oils | Anti-diabetes, cardiovascular disease, cancer, renal disease, obesity, treating inflammatory bowel disease, dental caries |
21. | Ammi visnaga | Visnagin, khellin, γ-pyrones, scopoletin, dehydrogeijerin, furanochromones, pyranocoumarins, apigenin, luteolin, chrysoeriol, essential oils | Vasodilator agents, treatment of skin disorders like psoriasis and vitiligo, treatment of renal colic, abdominal cramps, mild anginal symptoms |
22. | Baccharis megapotamica | Baccharine, clerodane, labdane diterpenoids, oleanane triterpenoids, cinnamic caid, coumarins, flavonoids | Reducing phlegm, relieving cough, invigorating blood circulation, inducing diuresis, antihelmintic, anti-inflammatory, anti-neoplastic, antioxidant, antiviral |
23. | Catharanthus roseus | Serpentine, ajmalicine, vinblastine, vincristine, tabersonine, vindoline, vinceine | Anti-cancer, anti-diabetic, treatment of Hodgkin’s disease, antineoplastic drug |
24. | Coptis species | Berberine, palmatine, epiberberine, coptisine, jatrorrhizine | Antipyretic, antidote, anti-inflammatory, neuroprotective, antioxidant |
25. | Dioscorea species | Diosgenin, discoeine, cortisone, allantoin, phytic acid, coumaric acid, myricetin | Anti-tumor, anorexiant, antifungal, antimutagenic, hypoglycemic, immunomodulatory, antidotes in inscet and snake bites |
26. | Panax ginseng | Ginsenosides (dammarane and oleanane) | Tonic for gastro enteric disorders, diabetes, anti-stress agents, cardioprotective, antioxidant, anxiolytic, anticancer, aphrodisiac |
27. | Digitalis lanata | Odoroside H, odorobioside G, verodoxin, glucodogifucoside, strospeside, digitoxin, digoxin, ouabain, oleandrin, proscillaridin | Treatment of congestive heart failure, cytotoxic, antidiabetic, antioxidant, insecticidal, immunological, hepato, neuro, cardioprotective properties |
28. | Beta vulgaris | Betalains, apigenin flavonoids like vitexin, vitexin-2-O-rhamnoside, vitexin-2-O-xyloside | Antihypertensive, hypoglycaemic, antioxidant, anticancer agent, natural dye in food industry |
29. | Atropa belladona | Tropane alkaloids (atropine, hyoscyamine and scopolamine) | Treatment of Parkinson’s disease, hallucinogenic agent, treatment of ulcers, motion sickness, inflammation, antidote for snake bites |
30. | Anisodus luridus | Tropane alkaloids(anisodamine, anisodine and hyoscyamine), piperidine, pyridine alkaloid | Anticholinergic, anaesthetic agents, treatment of septic shock |
31. | Heimia salicifolia | Quinolozidine, alkaloids, nesodine, vertine, lyfoline, lythrine, demethylsubine I & II | Antisyphilitic, sudorific, antipyretic, laxative and diuretic activity, agents to reduce psychodysleptic activity |
32. | Camptotheca acuminata | Camptothecin, 10-hydroxycamptothecin, 10‐methoxycamptothecin | Anti‐cancer agents |
33. | Hypericum perforatum | Hypericinn, hyperforin | Antidepressant, anti-inflammatory, antiviral, anti-cancer, antioxidant, nueroprotective, antibacterial activities |
34. | Maclura pomifera | Prenylated isoflavones (scandenone and auriculasin), isoflavones (osajin and pomiferin) | Astringent, antioxidant and fungicidal agents, cardiovascular activity, insect repellant, natural dye |
35. | Commiphora wightii | monoterpenoids, sesquiterpenoids, diterpenoids, triterpenoids, steroids, flavonoids, guggultetrols, lignans | Treat inflammation, gout, rheumatism, obesity, disorders of lipids metabolism |
36. | Pueraria lobata | Isoflavonoid (puerarin, daidzin and daidzein) | Antipretic, antidiarrhetic, diaphoretic, antiemetic, antioxidant agent |
37. | Chlorophytum borivilianum | Phenols, saponins, flavonoids, alkaloids, tannins, steroids, triterpenoids, vitamins | Effective aphrodisiac and pro-erectile agent, spermatogenic, immunomodulatory, anti-stress, anti-oxidant activities |
38. | Bacopa monnieri | Triterpenoid saponins (bacosides) | Nerve tonic, memory promoter, epilepsy, hepatoprotective, antioxidant |
39. | Citrullus colocynthis | Saponins, steroids, alkaloids and flavonoids, curcubitacins | Abortifacient, treat constipation, oedema, bacterial infections, cancer, diabetes |
2. Plant tissue culture and secondary metabolite(s) production
Consumers are becoming more conscientious about lifestyle choices which have spiked the demand for natural and organic products. The interest in medicinal plants increased in last two decades because of their health benefits in terms of safety and cost compared to synthetic drugs [[14], [15], [16]]. Recently, herbal medicine industry is one of the quickest emerging industries worldwide. The world trade in medicinal plants and their metabolites in the year 2000 was US$ 60 billion, with average yearly growth rate of 7 % and is anticipated to touch US$ 5 trillion by 2050 [17]. In the year 2002, 4 billion individuals of the global population were reported to utilize herbal medicines for their crucial health attention [18].
Plant metabolites can be isolated from naturally grown plants, but their commercial production is limited due to environmental and regional constraints [13]. Conventional methods are time consuming as plant takes several years to grow and reach the point for desired metabsolite production. An alternate method to surpass such situation is to use PTC techniques for the production of secondary metabolites efficiently within a short duration for commercial application [12,19]. It approvals the bulk propagation of plants in controlled environmental conditions without any seasonal constraints [20,21].
2.1. Types of in vitro systems for metabolite(s) production
In vitro secondary metabolites production is a two-stage procedure: (i) Aggregation of biomass, and (ii) Synthesis of secondary metabolites [13,20]. Organized structures like shoots and roots, calli, cell suspension, etc. were reportedly employed for production of secondary metabolites [8,22].
Under in vitro conditions, induced plant cells form unorganized mass of cells known as callus. For induction of callus, high amount of auxin concentrations or amalgamation of auxin and cytokinin is commonly used. Callus cultures have gained commercial potential for the manufacture of secondary metabolites of therapeutic significance [23,24]. Callus culture has been reported to be more reliable than collecting plant materials from wild for extracting the therapeutic metabolites [25]. They can be used for the generation of multiple clones of plants using micropropagation, and can also be used to develop single-cell suspension cultures employing either batch or continuous fermentation to produce the preferred secondary metabolites [26,27]. Subsequently, callus and suspension cultures have the ability to synthesize secondary metabolites and it enables the manipulation of secondary metabolites biosynthesis pathways. It has been reported that callus cultures used for the production of tropane alkaloids, α-tocopherol, ajmaline, serpentine, reserpine, flavonoids, scopolamine, paclitaxel, stilbene, resveratrol and anthocyanins [25].
Differentiated organ cultures like shoots or roots have been reported for metabolite production and can represent a metabolite profile similar to native plants [28]. Plant hairy root cultures are the furthermost auspicious alternative method for development of compounds synthesized in plant roots [29]. Agrobacterium rhizogenes arbitrated transformation has been used to trigger hairy roots in plants which has enabled in vitro construction of secondary metabolites synthesized in roots of plant [30,31]. They have established a beneficial biological scheme to study the biosynthesis of several bioactive compounds like nicotine and tropane alkaloids and [32,33], ginsenosides [34], anthraquinones [35] and artemisinin [36]. The advantage of using hairy roots for the development of compounds relies in their high productivity, constancy and competence [[37], [38], [39]].
3. Secondary metabolite(s) production strategies
Secondary metabolite production is an imperative technique having immense commercial application. Consistent production and high yields are the important factors in commercial development of secondary metabolites [40,41]. Traditional and metabolic engineering approaches have been utilized to enhance the construction and yields of secondary metabolites [42].
3.1. Traditional strategies
Secondary metabolites are produced as an outcome of primary metabolism. It is dependent on the rates at which substrates from primary metabolic pathways are re-routed to secondary biosynthetic pathways. Their synthesis depends on biotic as well as abiotic factors like growth and physiology, temperature, humidity, light intensity, etc. Metabolite productivity of in vitro cultures are dependent on culture media composition, pH, inoculum density, culture environment like temperature, light density, agitation, aeration, etc. [21,42]. Thus to improve the growth and metabolite productivity these factors has to be optimized. The choice of suitable culture media plays a vital role in secondary metabolites manufacture. The components of culture medium like macro- and micronutrients, vitamins, carbohydrates (sugars), and amino acids, and plant development regulators for example cytokinins, auxins, gibberellins, jasmonates and salicylates influence metabolite production [39].
Effective approaches to enhance biotechnological production of secondary metabolites are using elicitors which trigger secondary metabolic pathway to stimulate plant defense to protect the plant cell [43]. Elicitors can be divided on the basis of their source i.e., biotic and abiotic. Abiotic elicitors are constituents of non-biological sources like most of the inorganic compounds for example salts of heavy metals, metal ions, metal oxides, etc. [44,45]. Physical stresses such as cold shock, UV, osmotic, water stress, etc. have been reported to induce enzymatic activity and secondary metabolism [46].
Biotic elicitors are originate from biological source and they can be either exogenous or endogenous. Exogenous biotic elicitors are constituents of microbial cell walls like chitosan, chitin, or components of plant cell wall like polysaccharides or oligosaccharides. Polysaccharides or oligosaccharides are reported to be the furthermost premeditated signalling molecules for elicitation routes because it induces plant defense responses similar to pathogen invasion [47]. Endogenous biotic elicitors are polysaccharides (released by deterioration of the plant cell wall due to pathogens), intracellular molecules or proteins like salicylic acid or methyl jasmonate produced by the plant in reaction to various stress or pathogenic invasion [45]. Biotic elicitors are perceived by particular cell membrane receptors, and then transfer the stimulus to cell by signal transduction leading to the development of phytoalexins [43].
Phytohormones like salicylic acid and methyl jasmonate produced in plants in response to stress or pathogen invasion have been reported to be the signalling compounds in elicitation leading to an enhanced production of secondary metabolites like flavonoids, alkaloids, terpenoids and phenylpropanoids [[48], [49], [50], [51], [52]]. They initiate signal transduction pathways by targeting secondary signals in the cell nucleus which in turn lead to transcriptional stimulation of various genes thereby inducing the synthesis of an array of proteins involved in defense or resistance and secondary metabolites [53,54].
Many secondary metabolic pathways were reported to be triggered by microbes (fungi, bacteria, viruses, yeast, etc.). The use of bacterial, fungal and yeast extracts to induce secondary metabolites has been gaining attention due to improved yield and quality of metabolites. The most effective method to increase the productivity of secondary metabolites in PTC is the use of fungal elicitors [55]. It induces the expression of specific plant genes, activating secondary metabolic pathways thus increasing secondary metabolites [56]. It induces plant phytoalexins in the course of physiological progressions of plant disease resistance [57]. Fusarium, Pythium, yeast, Aspergillus, PenicilIium, Trichoderma species, etc. are frequently extracted as fungal elicitors and are used to induce secondary metabolites in medical plants [58,59].
Aspergillus niger and Saccharomyces cerevisiae cell free extracts were employed as fungal elicitors for improved gymnemic acid production from cell suspension cultures of Gymnema sylvestre [60]. Aspergills flavus was reported to increase the production of terpenoid indole alkaloids in Catharanthus roseus [59]. Bacterial elicitors are also be used to enhance the production of secondary metabolites. Gram-positive and Gram-negative strains of bacteria were used as elicitors for tropane alkaloids biosynthesis in adventitious hairy root cultures of Scopolia parviflora [61]. Kang et al. [62] recorded the enhanced production of ginkgolide and bilobalide biosynthesis in Gingko biloba cell suspension cultures using Staphylococcus aureus extract. Rhizobacterium elicitor treatment leads to a slow expansion of hypericin and pseudohypericin in plantlets of Hypericum perforatum [63]. The phytotoxin coronatine produced by Pseudomonas syringae has the received considerable attention as an elicitor for enhanced the production of secondary metabolites. Taxane production was reported to be enhanced by accumulation of coronatine in Taxus cell cultures [64]. Similarly, coronatine triggered the synthesis of viniferins in the cell suspension culture of Vitis vinifera [65]. Rhizobium leguminosarum and Agrobacterium tumefaciens bacterial elicitors were described to increase the production of glycyrrhizic acid from root culture of Taverniera cuneifolia [66].
3.2. Metabolic engineering
Metabolic engineering is the amendment of metabolic routes in an organism using modern biological tools like genomics, proteomics, metabolomics, etc. to produce metabolites of commercial importance [67]. It thus allows manipulation of endogenous biochemical pathways. It involves over expression or down regulation of metabolic pathways by diverting common precursors, enzymes, regulatory proteins with the help of recombinant DNA technology. Plants contain numerous metabolic pathways accountable for the biosynthesis of complex metabolites. These pathways can be reconstituted in heterologous hosts for overproduction and isolation of economically important pant metabolites.
The biosynthetic routes for production of secondary metabolites in plants are arise from the shikimate, polyketide and terpenoid routes. The shikimate pathway is highly conserved and reported to be the main source of phenylpropanoids and aromatic compounds [68]. It is considered as an essential metabolic pathway in plants in relations to carbon flux, as it is expected that more than 30% of fixed carbon is fixed via. this pathway [69]. The phenolic secondary metabolites in plants are derived from phenylalanine via. shikimate biosynthesis. The intermediate p-coumaroyl-CoA forms the origin of metabolites like coumarins, flavonoids, lignans, stilbenoids, catechins, vanillin, gallic acid, betalains, etc.
The terpenoid pathway is also known as isoprenoid pathway. Terpenoid biosynthesis in plants use two autonomous pathways i.e. mevalonic acid pathway (MVA) and methyl-D-erythritol (MEP) pathway. The MVA pathway serves the precursors for synthesis of brassinosteroids, sesquiterpenoids, phytosterols, triterpenoids, and polyprenols. MEP pathway is used for the biosynthesis of monoterpenoids, diterpenoids, hemiterpenoids, tocopherols, plastoquinones, plant growth regulators like cytokinins, gibberellins, etc. Terpenoids accounts for more than one third of the plant secondary metabolites and execute several functions in plant. For example, volatile terpenoids (monoterpenoids) and carotenoids are used as pollinator attractants, phytoalexins (sesquiterpeniods, diterpenoids and triterpenes) used as antimicrobial agents, antifeedants and protection against abiotic stress, monoterpenes and sesquiterpenes used as resistance against several predators (killers). Besides, it acts as a source for the formation of naphthoquinones, cannabinoids, furanocoumarines, anthraquinones and terpenoid indole alkaloids [70].
The polyketide route executes a vital role in fatty acids biosynthesis. They are derived from either acetyl CoA or malonyl CoA. Secondary metabolites established from the polyketide pathway include acetogenins, jasmonates 6-methylsalicylic acid, plumbagin, coniine and anthraquinones [70].
3.2.1. Up-regulating pathways
Proteins that bind to specific sites i.e., promoter or enhancer region of DNA to control the transcription or expression of target genes are called transcription factors. They decode information in genome and modulate the rate of transcription [71,72]. They have two functional regions namely an activator domain and a DNA binding domain. DNA binding domain possess amino acids which identify specific DNA base on the regulatory element while activator domain possess binding sites called activation functions and trans-activation domain for other proteins (transcription co-regulators).
Several transcription factors have been identified for secondary metabolite production. MYB transcription factors have been described to be the controllers of several biosynthetic routes in several species of plants. Transcription factors like R2R3-MYB, WD repeat (beta-transducin repeat), a elementary helix-loop-helix genes (bHLH genes), adenine nucleotide translocator (or adenine nucleotide translocase or Ant) type 1, APETALA2/ethylene response factor (AP2/ERF), WRKY, NAC, SQUAMOSA Promoter Binding Protein-Like (SPL) have been reported to control anthocyanin accumulation as well as flavonoids in plant species like Arabidopsis, Petunia hybrida, Zea mays, Solanum lycopersicum, Ipomoea batatas, etc. [[73], [74], [75]].
The MYB family proteins are involved in activating the phenylpropanoid pathway which regulates anthocyanin production. The expression of transcription factor MYB12 in developing seedlings of Arabidopsis thaliana resulted in an increase in total flavanoid content [73]. In Arabidopsis anthocyanin biosynthetic genes are activated by the formation of transcriptional regulation complex when MYB proteins communicate with bHLH proteins in the existence of a WD40 repeat [76]. In C. roseus three transcription elements ORCA1, ORCA2 and ORCA3 have been recognized to be involved in the expression of terpenoid indole alkaloid biosynthesis. Overexpression of ORCA2 or ORCA3 in C. roseus cell suspension/hairy roots boosted the synthesis of metabolites like ajmalicine, serpentine, tryptamine and catharanthine [77]. The addition of catharanthine, vindoline, strictosidine and ajmalicine increased significantly when ORCA3 was overexpressed [78].
In Artemisia annua, two jasmonic acid responsive transcription factor AP2/ERF proteins (AaERF1 and AaERF2) bind to the promoter’s genes which catalyzes artemisinin synthesis. An improved buildup of artemisinin and artemisinic acids was reported when AaERF1 or AaERF2 proteins were overexpressed [79]. AaWRKY1 transcription factor bind to activate the sesquiterpene synthase gene promoter for biosynthesis of artemisinin in Artemisia annua [80]. Transcription factor GaWRKY1 contracts to the promoter of (+)‐δ‐cadinene synthase genes and regulate gossypol biosynthesis [81]. One of the largest transcription factor families in plants is NAC domain‐containing proteins. These proteins control numerous developmental pathways and are produced in response to various biotic and abiotic stresses. In Arabidopsis the regulator of camalexin was reported to be a NAC protein ANAC042. The challenging factor in up regulating pathways is to find a transcription factor that concert on precise pathway genes [82]. An alternative to such challenge is to produce synthetic transcription factors, which target more than single gene of significant [83].
3.2.2. Redirecting common precursors
Enzymes compete for precursors in a biosynthetic pathway. Metabolite production can be increased by altering the precursor towards the biosynthesis of the target metabolites by hindering the competitive pathway or by inducing over expression of genes in the precursor pathway [70].
In tomato mutant taxadiene production can be enhanced by increasing the expression of gene that deciphers taxadiene synthase which is a precursor in the carotenoid pathway. Jadaun et al. [84] reported the over‐expression of 1‐deoxy‐d‐xylulose‐5‐phosphate synthase (GrDXS) led to enhanced terpenoidal secondary metabolite accumulation in Pelargonium spp. (essential oil) and Withania somnifera (withanolides). In peppermint and lavender the over expression of genes in precursor pathways led to an increase in the monoterpene content in essential oils [85,86]. The direct over expression of genes related to the alkaloid pathway was effective in increasing the alkaloid buildup in C. roseus [87].
3.2.3. Targeting metabolites to specific cell compartments
The enzymes and metabolites of secondary metabolic pathways are confined in cytoplasm and organelles like peroxisomes, vesicles, vacuoles, etc. The enzymes for secondary metabolic pathways are coordinated into multifunctional enzyme complexes associated with substrate channeling effects where metabolic output of one enzyme act as a substrate for the subsequent enzyme [88,89].
Specific amino acid sequences are reported to target and retain proteins to particular organelles [90]. In C. roseus the enzymes associated with the biosynthesis of monoterpenoid indole alkaloids are located in roots, leaves, flowers, buds, etc. while the metabolite accumulates in special cells called idioblasts and laticifers. The enzymes and metabolites produced have to be transported not to a cell but between cells belonging to different types of tissue [91]. To protect cells from self-toxicity, cells compartmentalize the reactions that synthesis harmful metabolites. Alkaloid berberine syntheisized by Coptis japonica and nicotine in tobacco are sequestered in vacuoles [92,93]. Different enzymes like chalcone synthase, chalcone isomerase, and dihydroflavonol 4-reductase collaborate together for flavonoid biosynthesis in Arabidopsis thaliana [94]. Zhang et al [95] reported the transport of anthocyanins from petals to the central vacuole by intracellular vesicles or pre-vacuolar compartments in Eustoma grandiflorum. The multifunctional dimeric enzyme glutathione S-transferases and a vacuolar flavonoid/H+-antiporter is reported to mediate the vacuolar transport of anthocyanin and proanthocyanidin in Arabidopsis thaliana [96].
3.2.4. Down-regulating pathways (silencing)
The synthesis of some metabolites can be diminished by curtailing the level of enzyme, increasing catabolism and carbon flux into competitive pathways [70]. Unwanted metabolites produced can be impeded by concealing genes that upregulate the metabolic pathway or increase their catabolism [97]. To phase out undesirable metabolites modern r-DNA technologies like antisense RNA, RNA interference (RNAi), co-supression can be used. RNA interference has been reportedly used to manipulate plant secondary metabolites like phenylpropanoids, alkaloids and terpenoids. Manipulating the phenylpropanoid pathway using RNAi has led to copious coloration in flowers, low seed coat pigment etc. It has been reportedly used to increase the production of codeine and morphine in the opium poppy, decrease the cyanogenic glucoside components of cassava, enhancing flavonoids and carotenoids in tomato, regulate fragrance in petunia flowers, etc. [98].
4. Nanoparticles for secondary metabolite(s)
The particles within the size range of 1–100 nm are known as nanoparticles. These have been used in plant tissue culture to promote germination efficiency, boost plant growth, ameliorate bioactive metabolites, etc. [99,100]. The effects of some important metal oxide nanoparticles like titanium oxide, zinc oxide, iron oxide and copper oxide have been reported for improved secondary metabolite production in plants [101,102]
Titanium oxide naoparticles distinctly increased gallic acid, chlorogenic acid, o-coumaric acid, tannic acid and cinnamic acid in embryonic calli of Cicer arietinum [102]. Silver nanoparticle treatment increased the concentration of artemisinin content in Artemisia annua L. hairy root cultures [57], diosgenin concentration in fenugreek [103], up regulation of biosynthetic genes for anthocyanin and flavonoid production in Arabidopsis thaliana, etc. [104]. Cadmium oxide nanoparticles resulted in an enhanced concentration of ferulic acid and isovitexin in barley plants [105].
5. Medicinally important plants and their secondary metabolites
Plant tissue culture research has resulted in the production of diverse bioactive molecules in bulk quantities for therapeutics. Secondary metabolites like alkaloids, terpenoids, steroids, saponins, phenolics, flavanoids, amino acids, etc. are used in many pharmaceutical preparations [106]. Few medicinally important plants and their important metabolites are listed below.
5.1. Catharanthus roseus
Catharanthus roseus (L.) G. Don (Apocynaceae) is an important medicinal plant due to the presence of metabolites like monoterpene indole alkaloids or terpenoid indole alkaloids [107]. It is used in traditional medicine to control cancer, diabetes, hypertension, antimicrobial agents, etc. The alkaloid content was reported to be highest at the flowering stage [108]. The main alkaloids in root are ajmalicine, serpentine, and reserpine. Vincolidine, vincoline, vindolindine, cathindine, vinblastin, catharanthamine, vinblastine, catharicine, catharine, leurosinone, cathindine, cavincidine, apparicine, β-carboline, iochrovicine, rosicine, serpentine, etc. are the major alkaloids reported in leaves. Coronaridine, vindolidine, vindoline, catharanthine, ajmalicine, perivine, tetrahydroalstonine, tabersonine, carosine, catharicine, etc. alkaloids dominate the flowers [109,110]. Catharanthus longifolius, Catharanthus trichophyllus, and Catharanthus lanceus are reported to possess vindoline type alkaloids [111].
It also produces a range of phenolic compounds like 2,3-dihydroxybenzoic acid, salicylic acid; salicylic acid glucoside, benzoic acid, gallic acid, glucovanillin, vanillic acid, 2,5- dihydroxybenzoic acid, 2,5-dihydroxybenzoic acid glucoside, etc. [112,113]. Phenylpropanoids like flavonoids, anthocyanins, cinnamic acid derivatives, are also reported in Catharanthus [114].
These phytochemicals are present in very low quantities in plant hence, to improve the phytochemical production in vitro methods are employed [115]. In vitro culture methods like callus culture, cell suspension, hairy root, etc. have been reported as advanced strategies over conventional breeding methods for the production of therapeutically important alkaloids [116,117].
Hairy root cultures of C. roseus transformed by Agrobacterium rhizogenes have been effectively employed for production of catharanthine, tabersonine, lochnericine, horhammericine indole alkaloids [118]. The alkaloid ajmalicine and serpentine has been obtained from calli, cell suspensions, sprouts, pilose roots; alstonine from calli; antirhine and cathindine in cell suspensions; acuamicine and lochnericine in calli and suspensions; horhammericine and vindoline in suspensions and sprouts; tabersonine in calli and suspensions; catharanthine in suspensions, sprouts and roots; 3,4-anhydrovinblastine and catharine in sprouts; vinblastine in calli, sprouts and somatic embryos; and vincristine in sprouts and embryos [107,119,120]. Liu et al. [121] reported the use of artemisinic acid as an elicitor for enhanced production of vindoline and vinblastine production in cell suspension of C. roseus.
5.2. Hypericum perforatum
Hypericum perforatum L. (Hypericaceae) is widely used in traditional and conventional medicine. In vitro and in vivo clinical studies report antiviral, antifungal, antibacterial, wound-healing, antidepressant, antioxidant properties, etc. [122,123]. The medicinal properties of the plant are ascribed to the presence of secondary metabolites like phloroglucinols (hyperforin, hyperfoliatin, adhyperforin), naphtodianthrones (hypericin, pseudohypericin), flavonoids (rutin, quercetin, quercitrin, isoquercitrin, hyperoside and amentoflavone), tannins (cathechin and epicatechin), proanthocyanidins (procyanidin B2) and bioflavonoids (biapigenin and amentoflavone) and small amounts of essential oil [[124], [125], [126], [127]]. The active phytochemical principle in plant varies depending on various ecological factors like plant habitat, development, etc. One of the major metabolite of this plant is hypericin has gained interest due to its potential as an anticancer agent [128,129].
In vitro culture systems have been reported as a substitute for the large scale production of metabolites of pharmaceutical interest [28,130]. The overproduction of naphtodianthrones from cell suspension cultures of H. perforatum have been customized using phytohormones and different elicitors [47,127,131].
5.3. Coleus forskohlii
Coleus forskohlii (Lamiaceae/Labiatae) is a medicinal plant used in Indian Ayurvedic Medicine. It contains the secondary metabolite labdane diterpenoid forskolin which is reported to have several biological and pharmacological activities [132]. Forskolin acts as an activator of adenylate cyclase [133]. The solitary source of forskolin is the roots of C. forskohlii plants but the concentration of the metabolite from wild plants in natural habitats is very less [134]. Plant tissue culture techniques thus have a potential for industrial production of bioactive metabolite forskolin. Callus induced from young leaves of C. forskohlii plants reported the presence of forskolin [133]. Elicitors like salicylic acid and methyl jasmonate had an intense effect on forskolin production [135].
5.4. Taxus baccata
Taxus baccata (English yew) is an evergreen conifer abundantly seen in central and southern Europe. The complex diterpene alkaloid taxol (plaxitaxol) isolated from bark of the Taxus tree is one of the most potent anticancer agent due to its mode of action on microtubules. Taxol binds to β-tubulin subunit, leading to interference with their normal breakdown during cell division with resultant stabilization of the polymer through protection from disassembly [[136], [137], [138]]. The ever-increasing demand for the alkaloid cannot be met by conventional extraction from the trees due to impeded growth of Taxus trees and the reduced taxol content in bark [41,139,140]. Hence, in vitro methods employing plant tissue culture are gaining more importance for commercial production of the metabolite taxol. Apart from Taxus species few gymnosperms, angiosperms and several endophytes have been reported for taxol production [141,142].
In vitro taxol production was first reported by Christen et al. [143]. Plant cell culture has been reported as a potent and sustainable means to produce paclitaxel from species like Taxus baccata, Taxus yunnanensis, Taxus cuspidate, Taxus chinensis, Taxuscanadensis and Taxus globosa [140]. Effective ways reported to increase the yield of paclitaxel involves the use of high-yielding cell lines, two-stage culture systems, carbohydrate optimization, pre-feeding strategies and fungal inducers like fungal extracts along with elicitors like salicylic acid, chitosan, squalene, methyl jasmonate, etc. [144,145] reported high taxane production in cell cultures which were deep brown and had reduced growth index.
5.5. Nothapodytes foetida
Nothapodytes foetida is an endangered species distributed in the Western Ghats of India succeeding worldwide significance owing to their pharmacological and therapeutic properties. It yields camptothecin a monoterpenoid indole alkaloid used in anticancer drug formulation [146]. It is also obtained from several plants like Camptotheca acuminata, Ophiorrhiza species, Ervatamia heyneana, Meriilliodendron megacarpum and Nothapodytes nimmoniana [147,148]. Camptothecin is formed in several parts of Nothapodytes foetida at adaptable amount [149] and the content of alkaloid increases with the age of the plant [150].
6. Conclusion and perspectives
Plants have been used for medical purposes since the ancient time. Increasing demand of sustainable and cost-effective natural phytochemicals from plants demands their mass cloning through plant tissue culture approaches. A huge number of medicinal plants and their metabolites have been produced by in vitro techniques in a short duration of time compared to conventional approaches. To meet the growing demand of these natural metabolites various strategies have been employed to produce plants with enticing features for metabolite production.
Author contributions
MM and HC: conceived the idea of the review, provided the general concept and inputs for each specific section, and drafted part of the manuscript. HC, MM, and TSB: wrote the review after collecting literature. MM: edited, compiled, and finalized the draft. MM and KS: approved the final version of the manuscript. Finally, all the authors read and approved it for publication.
Declaration of Competing Interest
The authors declare that there is no potential conflict of interest.
Acknowledgments
The author, MM is thankful to Mohanlal Sukhadia University, Udaipur, Rajasthan, India for providing the necessary facilities during the course of study. This work was supported by Startup Research Grant (UGC Faculty Research Promotion Scheme; FRPS). Authors are highly grateful to the authorities of respective departments for support in doing this work.
Footnotes
Supplementary material related to this article can be found, in the online version, at doi:https://doi.org/10.1016/j.btre.2020.e00450.
Appendix A. Supplementary data
The following is Supplementary data to this article:
References
- 1.Winter J.M., Tang Y. Synthetic biological approaches to natural product biosynthesis. Curr. Opin. Biotechnol. 2012;23:736–743. doi: 10.1016/j.copbio.2011.12.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Yuan H., Ma Q., Ye L., Piao G. The traditional medicine and modern medicine from natural products. Molecules. 2016;21(5):559. doi: 10.3390/molecules21050559. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Nasri H., Baradaran A., Shirzad H., Rafieian-Kopaei M. New concepts in nutraceuticals as alternative for pharmaceuticals. Int. J. Prev. Med. 2014;5(12):1487–1499. [PMC free article] [PubMed] [Google Scholar]
- 4.Atanasov A.G., Waltenberger B., Pferschy-Wenzig E.M., Linder T., Wawrosch C., Uhrin P., Temml V., Wang L., Schwaiger S., Heiss E.H., Rollinger J.M. Discovery and resupply of pharmacologically active plant-derived natural products: a review. Biotechnol. Adv. 2015;33(8):1582–1614. doi: 10.1016/j.biotechadv.2015.08.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Schulz V., Hänsel R., Tyler V.E. Springer-Verlag; Berlin: 2001. Rational Phytotherapy. A Physician’s Guide to Herbal Medicine. [Google Scholar]
- 6.Rosenthal G.A. The biochemical basis for the deleterious effects of L-canavanine. Phytochemistry. 1991;30:1055–1058. [Google Scholar]
- 7.Ncube B., Van Staden J. Tilting plant metabolism for improved metabolite biosynthesis and enhanced human benefit. Molecules. 2015;20:12698–12731. doi: 10.3390/molecules200712698. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Guerriero G., Berni R., Muñoz-Sanchez J.A., Apone F., Abdel-Salam E.M., Qahtan A.A., Alatar A.A., Cantini C., Cai G., Hausman J.F., Siddiqui K.S., Hernández-Sotomayor S.M.T., Faisal M. Production of plant secondary metabolites: examples, tips and suggestions for biotechnologists. Genes (Basel) 2018;9(6):E309. doi: 10.3390/genes9060309. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Sandra G., Anabela R. Production of plant secondary metabolites by using biotechnological tools, secondary metabolites - Sources and applications. In: Vijayakumar R., editor. Secondary Metabolites Sources and Applications. Intech Open. 2018. [DOI] [Google Scholar]
- 10.Hussein R., El-Anssary A.A. Plants secondary metabolites: The key drivers of the pharmacological actions of medicinal plants. In: Builders P., editor. Herbal Medicine. Intech Open. 2018. pp. 11–30. [DOI] [Google Scholar]
- 11.McMurry J.E. Secondary Metabolites: An Introduction to Natural Products Chemistry. 2015. Organic chemistry with biological applications; pp. 1016–1046. Stamford, USA. [Google Scholar]
- 12.Kolewe M.E., Gaurav V., Roberts S.C. Pharmaceutical active natural product synthesis and supply viaplant cell culture technology. Mol. Pharm. 2008;5:243–256. doi: 10.1021/mp7001494. [DOI] [PubMed] [Google Scholar]
- 13.Yue W., Ming Q.L., Lin B., Rahman K., Zheng C.J., Han T., Qin L.P. Medicinal plant cell suspension cultures: pharmaceutical applications and high-yielding strategies for the desired secondary metabolites. Crit. Rev. Biotechnol. 2016;36:215–232. doi: 10.3109/07388551.2014.923986. [DOI] [PubMed] [Google Scholar]
- 14.Ekor M. The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety. Front. Pharmacol. 2014;4:177. doi: 10.3389/fphar.2013.00177. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Thomford N.E., Senthebane D.A., Rowe A., Munro D., Seele P., Maroyi A., Dzobo K. Natural products for drug discovery in the 21st century: innovations for novel drug discovery. Int. J. Mol. Sci. 2018;19(6):1578. doi: 10.3390/ijms19061578. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Anand U., Jacobo-Herrera N., Altemimi A., Lakhssassi N. A comprehensive review on medicinal plants as antimicrobial therapeutics: potential avenues of biocompatible drug discovery. Metabolites. 2019;9:258. doi: 10.3390/metabo9110258. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Government of India . 2000. Medicinal Plants Introduction, Indian System of Medicine and Homoeopathy (ISMH), Department of ISMH, Ministry of Health and Family Welfare, Govt. of India.http://indianmedicine.nic.in/html/plants/mimain.htm [Google Scholar]
- 18.World Health Organization; WHO . WHO; Geneva: 2002. Traditional Medicine; Growing Needs and Potential. WHO Policy Perspectives on Medicines; pp. 1–6. [Google Scholar]
- 19.Verpoorte R., Contin A., Memelink J. Biotechnology for the production of plant secondary metabolites. Phytochem. Rev. 2002;1:13–25. doi: 10.1023/A:1015871916833. [Google Scholar]
- 20.Murthy H.N., Lee E.J., Paek K.Y. Production of secondary metabolites from cell and organ cultures: strategies and approaches for biomass improvement and metabolite accumulation. Plant Cell Tissue Organ Cult. 2014;118:1–16. doi: 10.1007/s11240-014-0467-7. [DOI] [Google Scholar]
- 21.Ochoa-Villarreal M., Howat S., Hong S., Jang M.O., Jin Y.W., Lee E.K., Loake G.J. Plant cell culture strategies for the production of natural products. BMB Rep. 2016;49(3):149–158. doi: 10.5483/bmbrep.2016.49.3.264. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Hussain M.S., Fareed S., Saba Ansari M., Rahman A., Ahmad I.Z., Saeed M. Current approaches toward production of secondary plant metabolites. J. Pharm. Bioallied Sci. 2012;4(1):10–20. doi: 10.4103/0975-7406.92725. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Ogita S. Plant cell, tissue and organ culture: The most flexible foundations for plant metabolic engineering applications. Nat. Prod. Commun. 2015;10(5):815–820. [PubMed] [Google Scholar]
- 24.Wu C.F., Karioti A., Rohr D., Bilia A.R., Efferth T. Production of rosmarinic acid and salvianolic acid B from callus culture of Salvia miltiorrhiza with cytotoxicity towards acute lymphoblastic leukemia cells. Food Chem. 2016;201:292–297. doi: 10.1016/j.foodchem.2016.01.054. [DOI] [PubMed] [Google Scholar]
- 25.Efferth T. Biotechnology applications of plant callus cultures. Engineering. 2019;5(1):50–59. doi: 10.1016/j.eng.2018.11.006. [DOI] [Google Scholar]
- 26.Fischer R., Emans N., Schuster F., Hellwig S., Drossard J. Towards molecular farming in the future: using plant-cell-suspension cultures as bioreactors. Biotechnol. Appl. Biochem. 1999;30(2):109–112. [PubMed] [Google Scholar]
- 27.Xu J., Ge X., Dolan M.C. Towards high-yield production of pharmaceutical proteins with plant cell suspension cultures. Biotechnol. Adv. 2011;29:278–299. doi: 10.1016/j.biotechadv.2011.01.002. [DOI] [PubMed] [Google Scholar]
- 28.Karuppusamy S. A review on trends in production of secondary metabolites from higher plants by in vitro tissue, organ and cell cultures. J. Med. Plant Res. 2009;3:1222–1239. [Google Scholar]
- 29.Pence V.C. Evaluating costs for the in vitro propagation and preservation of endangered plants. In Vitro Cellular and Developmental Biology Plant. 2011;47(1):176–187. [Google Scholar]
- 30.Chen L., Cai Y., Liu X. Soybean hairy roots produced in vitro by Agrobacterium rhizogenes-mediated transformation. Crop J. 2018;6:162–171. [Google Scholar]
- 31.Palazón J., Piñol M.T., Cusido R.M., Morales C., Bonfill M. Application of transformed root technology to the production of bioactive metabolites. Recent Res. Dev. Plant Physiol. 1997;1:125–143. [Google Scholar]
- 32.Zhang L., Ding R., Chai Y., Bonfill M., Moyano E., Oksman-Caldentey K.M., Xu T., Pi Y., Wang Z., Zhang H., Kai G., Liao Z., Sun X., Tang K. Engineering tropane biosynthetic pathway in Hyoscyamus niger hairy root cultures. Proc. Natl. Acad. Sci. U.S.A. 2004;101(17):6786–6791. doi: 10.1073/pnas.0401391101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Yu K.W., Hosakatte N.M., Hahn E.J., Paek K.Y. Ginsenoside production by hairy root cultures of Panax ginseng: influence of temperature and light quality. Biochem. Eng. J. 2005;23:53–56. [Google Scholar]
- 34.Ha L.T., Pawlicki-Jullian N., Pillon-Lequart M., Boitel-Conti M., Duong H.X., Gontier E. Hairy root cultures of Panax vietnamensis, a promising approach for the production of ocotillol-type ginsenosides. Plant Cell Tissue Organ Cult. 2016;126:93–103. [Google Scholar]
- 35.Perassolo M., Cardillo A.B., Laura Mugas M., Núñez Montoya S.C., Giulietti A.M., Taloua A.R. Enhancement of anthraquinone production and release by combination of culture medium selection and methyl jasmonate elicitation in hairy root cultures of Rubia tinctorum. Ind. Crops Prod. 2017;105:124–132. doi: 10.1016/j.indcrop.2017.05.010. [DOI] [Google Scholar]
- 36.Patra N., Srivastava A.K. Artemisinin production by plant hairy root cultures in gas-and liquid-phase bioreactors. Plant Cell Rep. 2016;35:143–153. doi: 10.1007/s00299-015-1875-9. [DOI] [PubMed] [Google Scholar]
- 37.Thiruvengadam M., Rekha K., Chung I.M. Induction of hairy roots by Agrobacterium rhizogenesis-mediated transformation of spine gourd (Momordica dioica Roxb. Ex. Willd) for the assessment of phenolic compounds and biological activities. Sci. Horticult. 2016;198:132–141. doi: 10.1016/j.scienta.2015.11.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Thakore D., Srivastava A.K., Sinha A.K. Mass production of Ajmalicine by bioreactor cultivation of hairy roots of Catharanthus roseus. Biochem. Eng. J. 2017;119:84–91. [Google Scholar]
- 39.Cardoso J.C., de Oliveira B.E.B.S., de CI Cardoso F. Advances and challenges on the in vitro production of secondary metabolites from medicinal plants. Hortic. Bras. 2019;37(2):124–132. [Google Scholar]
- 40.Vijaya Sree N., Udayasri P.V.V., Aswani Kumar Y., Ravi Babu B., Phani Kumar Y., Vijay Varma M. Advancements in the production of secondary metabolites. J. Nat. Prod. 2010;3:112–123. [Google Scholar]
- 41.Gonçalves S., Romano A. Production of plant secondary metabolites by using biotechnological tools. In: Vijayakumar R., Raja S.S.S., editors. Secondary Metabolites - Sources and Applications. IntechOpen. 2018. [DOI] [Google Scholar]
- 42.Isah T., Umar S., Mujib A. Secondary metabolism of pharmaceuticals in the plant in vitro cultures: strategies, approaches, and limitations to achieving higher yield. Plant Cell Tissue Organ Cult. 2018;132:239–265. doi: 10.1007/s11240-017-1332-2. [DOI] [Google Scholar]
- 43.Baenas N., Garcia-Viguera C., Moreno D.A. Elicitation: a tool for enriching the bioactive composition of foods. Molecules. 2014;19:13541–13563. doi: 10.3390/molecules190913541. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Gorelick J., Bernstein N. Elicitation: An underutilized tool in the development of medicinal plants as a source of therapeutic secondary metabolites. In: Sparks D.L., editor. Vol. 124. Elsevier; Amsterdam, The Netherlands: 2014. pp. 201–230. (Advances in Agronomy). [Google Scholar]
- 45.Ramirez-Estrada K., Vidal-Limon H., Hidalgo D., Moyano E., Golenioswki M., Cusidó R.M., Palazon J. Elicitation, an effective strategy for the biotechnological production of bioactive high-added value compounds in plant cell factories. Molecules. 2016;21:182. doi: 10.3390/molecules21020182. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Ramakrishna A., Ravishankar G.A. Influence of abiotic stress signals on secondary metabolites in plants. Plant Signal. Behav. 2011;6:1720–1731. doi: 10.4161/psb.6.11.17613. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Zhao J., Davis L.C., Verpoorte R. Elicitor signal transduction leading to production of plant secondary metabolites. Biotechnol. Adv. 2005;23:283–333. doi: 10.1016/j.biotechadv.2005.01.003. [DOI] [PubMed] [Google Scholar]
- 48.Van der Fits L., Memelink J. ORCA3, a jasmonate responsive transcriptional regulator of plant primary and secondary metabolism. Science. 2000;289:295–297. doi: 10.1126/science.289.5477.295. [DOI] [PubMed] [Google Scholar]
- 49.Walker T.S., Bais H.P., Vivanco J.M. Jasmonic acid induced hypericin production in cell suspension cultures of Hypericum perforatum L. (St. John’s wort) Phytochemistry. 2002;60(3):289–293. doi: 10.1016/s0031-9422(02)00074-2. [DOI] [PubMed] [Google Scholar]
- 50.Kang S.M., Min J.Y., Kim Y.D., Kang Y.M., Park D.J., Jung H.N., Kim S.W., Choi M.S. Effects of methyl jasmonate and salicylic acid on the production of bilobalide and ginkgolides in cell cultures of Ginkgo biloba. In Vitro Cell Dev. Biol. Plant. 2006;42(1):44–49. doi: https://doi.org/10.1079/IVP2005719. [Google Scholar]
- 51.Siddiqui Z.H., Mujib A., Mahmooduzzafar Aslam J., Hakeem K.R., Parween T. In vitro production of secondary metabolites using elicitor in Catharanthus roseus: A case study. In: Hakeem K.R., Ahmad P., Ozturk M., editors. Crop Improvement, New Approaches and Modern Techniques. Springer Science and Business Media; Berlin, Germany: 2013. pp. 401–441. [Google Scholar]
- 52.Giri C.C., Zaheer M. Chemical elicitors versus secondary metabolite production in vitro using plant cell, tissue and organ cultures: recent trends and a sky eye view appraisal. Plant Cell Tissue Organ Cult. 2016;126:1–18. doi: 10.1007/s11240-016-0985-6. [DOI] [Google Scholar]
- 53.Siddiqui M.S., Thodey K., Trenchard I., Smolke C.D. Advancing secondary metabolites in yeast with synthetic biology tools. FEMS Yeast Res. 2012;12:144–170. doi: 10.1111/j.1567-1364.2011.00774.x. [DOI] [PubMed] [Google Scholar]
- 54.Singh A., Dwivedi P. Methyl-jasmonate and salicylic acid as potent elicitors for secondary metabolite production in medicinal plants: a review. J. Pharmacog. Phytochem. 2018;7:750–757. [Google Scholar]
- 55.Takeuchi C., Nagatani K., Sato Y. Chitosan and a fungal elicitor inhibit tracheary element differentiation and promote accumulation of stress lignin-like substance in Zinnia elegans xylogenic culture. J. Plant Res. 2013;126:811–821. doi: 10.1007/s10265-013-0568-0. [DOI] [PubMed] [Google Scholar]
- 56.Han X., Xu X., Cui C., Gu Q. Alkaloidal compounds produced by a marine-derived fungus, Aspergillus fumigatus H1-04, and their antitumor activities. Zhongguo Yaowu Huaxue Zazhi. 2007;17:232–237. [Google Scholar]
- 57.Zhang B., Zheng L.P., Li W.Y., Wang J.W. Stimulation of artemisinin production in Artemisia annua hairy roots by Ag-SiO2 core-shell nanoparticles. Curr. Nanosci. 2013;9:363–370. doi: 10.2174/1573413711309030012. [DOI] [Google Scholar]
- 58.Namdeo A., Patil S., Fulzele D.P. Influence of fungal elicitors on production of ajmalicine by cell cultures of Catharanthus roseus. Biotechnol. Progr. 2002;18:159–162. doi: 10.1021/bp0101280. [DOI] [PubMed] [Google Scholar]
- 59.Liang C., Chen C., Zhou P., Xu L., Zhu J., Liang J., Zi J., Yu R. Effect of Aspergillus flavus fungal elicitor on the production of terpenoid indole alkaloids in Catharanthus roseus cambial meristematic cells. Molecules. 2018;23(12):3276. doi: 10.3390/molecules23123276. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Chodisetti B., Rao K., Gandi S., Giri A. Improved gymnemic acid production in the suspension cultures of Gymnema sylvestre through biotic elicitation. Plant Biotechnol. Rep. 2013;7:519–525. doi: 10.1007/s11816-013-0290-3. [DOI] [Google Scholar]
- 61.Jung H.Y., Kang S.M., Kang Y.M., Kang M.J., Yun D.J., Bahk J.D., Yang J.K., Choi M.S. Enhanced production of scopolamine by bacterial elicitors in adventitious hairy root cultures of Scopolia parviflora. Enzyme Microb. Technol. 2003;33:987–990. doi: 10.1016/S0141-0229(03)00253-9. [DOI] [Google Scholar]
- 62.Kang S.M., Min J.Y., Kim Y.D., Karigar C.S., Kim S.W., Goo G.H., Choi M.S. Effect of biotic elicitors on the accumulation of bilobalide and ginkgolides in Ginkgo biloba cell cultures. J. Biotechnol. 2009;139:84–88. doi: 10.1016/j.jbiotec.2008.09.007. [DOI] [PubMed] [Google Scholar]
- 63.Manero F.J., Algar E., Martin Gómez M.S., Saco Sierra M.D., Solano B.R. Elicitation of secondary metabolism in Hypericum perforatum by rhizosphere bacteria and derived elicitors in seedlings and shoot cultures. Pharm. Biol. 2012;50:1201–1209. doi: 10.3109/13880209.2012.664150. [DOI] [PubMed] [Google Scholar]
- 64.Onrubia M., Moyano E., Bonfill M., Cusidó R.M., Goossens A., Palazón J. Coronatine, a more powerful elicitor for inducing taxane biosynthesis in Taxus media cell cultures than methyl jasmonate. J. Plant Physiol. 2013;170:211–219. doi: 10.1016/j.jplph.2012.09.004. [DOI] [PubMed] [Google Scholar]
- 65.Taurino M., Ingrosso I., D’amico L. Jasmonates elicit different sets of stilbenes in Vitis vinifera cv. Negramaro cell cultures. SpringerPlus. 2015;4:49. doi: 10.1186/s40064-015-0831-z. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66.Vithal A., Aniket K., Abhay H. Microbial elicitation in root cultures of Taverniera cuneifolia (Roth) Arn. for elevated glycyrrhizic acid production. Ind. Crops Prod. 2014;54:13–16. doi: 10.1016/j.indcrop.2013.12.036. [DOI] [Google Scholar]
- 67.DellaPenna D. Plant metabolic engineering. Plant Physiol. 2001;125(1):160–163. doi: 10.1104/pp.125.1.160. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Herrmann K.M., Weaver L.M. The shikimate pathway. Annu. Rev. Plant Physiol. Plant Mol. Biol. 1999;50(1):473–503. doi: 10.1146/annurev.arplant.50.1.473. [DOI] [PubMed] [Google Scholar]
- 69.Maeda H., Dudareva N. The shikimate pathway and aromatic amino acid biosynthesis in plants. Annu. Rev. Plant Biol. 2012;63:73–105. doi: 10.1146/annurev-arplant-042811-105439. [DOI] [PubMed] [Google Scholar]
- 70.Verpoorte R. Plant secondary metabolites. In: Verpoorte R., Alfermann A.W., editors. Metabolic Engineering of Plant Secondary Metabolism. Kluwer Academic Publisher, Dodrecht; Boston, London: 2000. pp. 1–30. [Google Scholar]
- 71.Latchman D.S. Academic Press; San Diego: 2003. Eucaryotic transcription factors. [Google Scholar]
- 72.Broun P. Transcription factors as tools for metabolic engineering in plants. Curr. Opin. Plant Biol. 2004;7(2):202–209. doi: 10.1016/j.pbi.2004.01.013. [DOI] [PubMed] [Google Scholar]
- 73.Yang C.Q., Fang X., Wu X.M., Mao Y.B., Wang L.J., Chen X.Y. Transcriptional regulation of plant secondary metabolism. Journal of Integrative Plant Biology. 2012;54:703–712. doi: 10.1111/j.1744-7909.2012.01161.x. [DOI] [PubMed] [Google Scholar]
- 74.Albert N.W., Davies K.M., Lewis D.H., Zhang H., Montefiori M., Brendolise C., Boase M.R., Ngo H., Jameson P.E., Schwinn K.E. A conserved network of transcriptional activators and repressors regulates anthocyanin pigmentation in Eudicots. Plant Cell. 2014;26(3):962–980. doi: 10.1105/tpc.113.122069. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Xu W., Dubos C., Lepiniec L. Transcriptional control of flavonoid biosynthesis by MYB-bHLH-WDR complexes. Trends Plant Sci. 2015;20:176–185. doi: 10.1016/j.tplants.2014.12.001. [DOI] [PubMed] [Google Scholar]
- 76.Dubos C., Stracke R., Grotewold E., Weisshaar B., Martin C., Lepiniec L. MYB transcription factors in Arabidopsis. Trends Plant Sci. 2010;15:573–581. doi: 10.1016/j.tplants.2010.06.005. [DOI] [PubMed] [Google Scholar]
- 77.Sun J., Peebles C.A.M. Engineering over expression of ORCA3 and strictosidine glucosidase in Catharanthus roseus hairy roots increases alkaloid production. Protoplasma. 2017;253:1255–1264. doi: 10.1007/s00709-015-0881-7. [DOI] [PubMed] [Google Scholar]
- 78.Pan Q., Wang Q., Yuan F., Xing S., Zhao J., Choi Y.H., Verpoorte R., Tian Y., Wang G., Tang K. Over expression of ORCA3 and G10H in Catharanthus roseus plants regulated alkaloid biosynthesis and metabolism revealed by NMR-metabolomics. PLoS One. 2012;7 doi: 10.1371/journal.pone.0043038. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 79.Yu Z.X., Li J.X., Yang C.Q., Hu W.L., Wang L.J., Chen X.Y. The jasmonate-responsive AP2/ERF transcription factors AaERF1 and AaERF2 positively regulate artemisinin biosynthesis in Artemisia annua. L. Mol. Plant. 2012;5:353–365. doi: 10.1093/mp/ssr087. [DOI] [PubMed] [Google Scholar]
- 80.Ma D., Pu G., Lei C., Ma L., Wang H., Guo Y., Chen J., Du Z., Wang H., Li G., Ye H., Liu B. Isolation and characterization of AaWRKY1, an Artemisia annua transcription factor that regulates the amorpha-4,11-diene synthase gene, a key gene of artemisinin biosynthesis. Plant Cell Physiol. 2009;50:2146–2161. doi: 10.1093/pcp/pcp149. [DOI] [PubMed] [Google Scholar]
- 81.Xu Y.H., Wang J.W., Wang S., Wang J.Y., Chen X.Y. Characterization of GaWRKY1, a cotton transcription factor that regulates the sesquiterpene synthase gene (+)-delta-cadinene synthase-A. Plant Physiol. 2004;135:507–515. doi: 10.1104/pp.104.038612. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 82.Kinney A.J. Metabolic engineering in plants for human health and nutrition. Curr. Opin. Biotechnol. 2006;17(2):130–138. doi: 10.1016/j.copbio.2006.02.006. [DOI] [PubMed] [Google Scholar]
- 83.Moore M., Ullman C. Recent developments in the engineering of zinc finger proteins. Brief Funct. Genomic Proteomic. 2003;1(4):342–355. doi: 10.1093/bfgp/1.4.342. [DOI] [PubMed] [Google Scholar]
- 84.Jadaun J.S., Sangwan N.S., Narnoliya L.K., Singh N., Bansal S., Mishra B., Sangwan R.S. Over‐expression of DXS gene enhances terpenoidal secondary metabolite accumulation in rose‐scented geranium and Withania somnifera: active involvement of plastid isoprenogenic pathway in their biosynthesis. Physiol. Plantarum. 2017;159:381–400. doi: 10.1111/ppl.12507. [DOI] [PubMed] [Google Scholar]
- 85.Mahmoud S.S., Croteau R.B. Metabolic engineering of essential oil yield and composition in mint by altering expression of deoxyxylulose phosphate reductoisomerase and menthofuran synthase. Proc. Natl. Acad. Sci. U.S.A. 2001;98(15):8915–8920. doi: 10.1073/pnas.141237298. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 86.Muñoz-Bertomeu J., Arrillaga I., Ros R., Segura J. Up–regulation of 1-deoxy-D-xylulose-5-phosphate synthase enhances production of essential oils in transgenic spike lavender. Plant Physiol. 2006;142(3):890–900. doi: 10.1104/pp.106.086355. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.Canel C., Lopes-Cardoso M.I., Whitmer S., van der Fits L., Pasquali G., van der Heijden R., Hoge J.H., Verpoorte R. Effects of over-expression of strictosidine synthase and tryptophan decarboxylase on alkaloid production by cell cultures of Catharanthus roseus. Planta. 1998;205:414–419. doi: 10.1007/s004250050338. [DOI] [PubMed] [Google Scholar]
- 88.Winkel B.S.J. Metabolic channeling in plants. Annu. Rev. Plant Biol. 2004;55:85–107. doi: 10.1146/annurev.arplant.55.031903.141714. [DOI] [PubMed] [Google Scholar]
- 89.Jorgensen K., Rasmussen A.V., Morant M., Nielsen A.H., Bjarnholt N., Zagrobelny M., Bak S., Moller B.L. Metabolon formation and metabolic channeling in the biosynthesis of plant natural products. Curr. Opin. Plant Biol. 2005;8:280–291. doi: 10.1016/j.pbi.2005.03.014. [DOI] [PubMed] [Google Scholar]
- 90.Lessard P.A., Kulaveerasingam H., York G.M., Strong A., Sinskey A.J. Manipulating gene expression for the metabolic engineering of plants. Metab. Eng. 2002;4:67–79. doi: 10.1006/mben.2001.0210. [DOI] [PubMed] [Google Scholar]
- 91.St-Pierre B., Vazquez-Flota F.A., De Luca V. Multicellular compartmentation of Catharanthus roseus alkaloid biosynthesis predicts intercellular translocation of a pathway intermediate. Plant Cell. 1999;11:887–900. doi: 10.1105/tpc.11.5.887. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 92.Saunders J.A. Investigations of vacuoles isolated from tobacco: quantitation of nicotine. Plant Physiol. 1979;64:74–78. doi: 10.1104/pp.64.1.74. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Otani M., Shitan N., Sakai K., Martinoia E., Sato F., Yazaki K. Characterization of vacuolar transport of the endogenous alkaloid berberine in Coptis japonica. Plant Physiol. 2005;138:1939–1946. doi: 10.1104/pp.105.064352. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 94.Burbulis I.E., Winkel-Shirley B. Interactions among enzymes of the Arabidopsis flavonoid biosynthetic pathway. Proc. Natl. Acad. Sci. U.S.A. 1999;96:12929–12934. doi: 10.1073/pnas.96.22.12929. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 95.Zhang H., Wang L., Deroles S., Bennett R., Davies K. New insight into the structures and formation of anthocyanic vacuolar inclusions in flower petals. BMC Plant Biol. 2006;6:29. doi: 10.1186/1471-2229-6-29. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 96.Marinova K., Pourcel L., Weder B., Schwarz M., Barron D., Routaboul J.M., Debeaujon I., Klein M. The Arabidopsis MATE transporter TT12 acts as a vacuolar flavonoid/H+-antiporter active in proanthocyanidin-accumulating cells of the seed coat. Plant Cell. 2007;19:2023–2038. doi: 10.1105/tpc.106.046029. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 97.Gómez-Galera S., Pelacho A., Gené A., Capell T., Christou P. The genetic manipulation of medicinal and aromatic plants. Plant Cell Rep. 2007;26:1689–1715. doi: 10.1007/s00299-007-0384-x. [DOI] [PubMed] [Google Scholar]
- 98.Wagner G.J., Kroumova A.B. The use of RNAi to elucidate and manipulate secondary metabolite synthesis in plants. In: Ying S.Y., editor. Current Perspectives in MicroRNAs (miRNA). Springer; Dordrecht: 2008. [Google Scholar]
- 99.Wang P., Lombi E., Zhao F.J., Kopittke P.M. Nanotechnology: a new opportunity in plant sciences. Trends Plant Sci. 2016;21:699–712. doi: 10.1016/j.tplants.2016.04.005. [DOI] [PubMed] [Google Scholar]
- 100.Ruttkay-Nedecky B., Krystofova O., Nejdl L., Adam V. Nanoparticles based on essential metals and their phytotoxicity. J. Nanobiotechnol. 2017;15:33. doi: 10.1186/s12951-017-0268-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Castiglione Monica R., Cremonini R. Nanoparticles and higher plants. Caryologia. 2009;62:161–165. [Google Scholar]
- 102.Mohammed A.E. Green synthesis, antimicrobial and cytotoxic effects of silver nanoparticles mediated by Eucalyptus camaldulensis leaf extract. Asian Pacific J. Trop Biomed. 2015;5(5):382–386. doi: 10.1016/S2221-1691(15)30373-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 103.Jasim B., Thomas R., Mathew J., Radhakrishnan E.K. Plant growth and diosgenin enhancement effect of silver nanoparticles in Fenugreek (Trigonella foenum-graecum L.) Saudi Pharm. J. 2017;25:443–447. doi: 10.1016/j.jsps.2016.09.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 104.Garcia-Sanchez S., Bernales I., Cristobal S. Early response to nanoparticles in the Arabidopsis transcriptome compromises plant defence and root-hair development through salicylic acid signalling. BMC Genomics. 2015;16:341. doi: 10.1186/s12864-015-1530-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 105.Večeřová K., Večeřa Z., Dočekal B., Oravec M., Pompeiano A., Tříska J., Urban O. Changes of primary and secondary metabolites in barley plants exposed to CdO nanoparticles. Environ. Pollut. 2016;218:207–218. doi: 10.1016/j.envpol.2016.05.013. [DOI] [PubMed] [Google Scholar]
- 106.Wink M. Modes of action of herbal medicines and plant secondary metabolites. Medicines. 2015;2(3):251–286. doi: 10.3390/medicines2030251. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107.Van der Heijden R., Jacobs D.I., Snocijer W., Hallard D., Verpoorte R. The Catharanthus alkaloids: pharmacognosy and biotechnology. Curr. Med. Chem. 2004;11:607–628. doi: 10.2174/0929867043455846. [DOI] [PubMed] [Google Scholar]
- 108.Schmelzer G.H., Gurib-Fakim A. PROTA Foundation, Backhuys, CTA, Wageningen; The Netherlands: 2008. Plant Resources of Tropical Africa: Medicinal Plants. [Google Scholar]
- 109.Junaid A., Sheba H.K., Zahid H.S., Zohra F., Mehpara M., Mukthar A.B., Sekh A.N., Ilah A., Iffat Z.A., Saeed A.K., Mujib A. Catharanthus roseus (L.) G. Don. An important drug: it’s applications and production. Pharm. Glob. IJCP. 2010;4:1–16. [Google Scholar]
- 110.Nejat N., Valdiani A., Cahill D., Tan Y.H., Maziah M., Abiri R. Ornamental exterior versus therapeutic interior of Madagascar periwinkle (Catharanthus roseus): the two faces of a versatile herb. Sci. World J. 2015:982412. doi: 10.1155/2015/982412. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 111.Daniel M. Science Publishers; 2006. Medicinal plants: chemistry and properties. [Google Scholar]
- 112.Naz S., Haq R., Aslam F., IIyas S. Evaluation of antimicrobial activity of extracts of in vivo and in vitro grown Vinca rosea L. (Catharanthus roseus) against pathogens. Pak. J. Pharm. Sci. 2015;28:849–853. [PubMed] [Google Scholar]
- 113.Sottomayor M., Lopes Cardoso I., Pereira L.G., Barceló A. Peroxidase and the biosynthesis of terpenoid indole alkaloids in the medicinal plant Catharanthus roseus (L.) G. Don. Phytochem. Rev. 2004;3:159–171. doi: 10.1023/B:PHYT.0000047807.66887.09. [DOI] [Google Scholar]
- 114.Mustafa N.R., Verpoorte R. Phenolic compounds in Catharanthus roseus. Phytochem. Rev. 2007;6(2-3):243–258. doi: 10.1007/s11101-006-9039-8. [DOI] [Google Scholar]
- 115.Naeem M., Aftab T., Masroor K.M.A. Springer; India: 2017. Catharanthus Roseus. Current Research and Future Prospects; p. 412. [DOI] [Google Scholar]
- 116.Moreno P.R., Van Der Heijden R., Verpoorte R. Cell and tissue cultures of Catharanthus roseus: a literature survey. Plant Cell Tissue Organ Cult. 1995;42(1):1–25. [Google Scholar]
- 117.Goldhaber-Pasillas G.D., Mustafa N.R., Verpoorte R. Jasmonic acid effect on the fatty acid and terpenoid indole alkaloid accumulation in cell suspension cultures of Catharanthus roseus. Molecules. 2014;19:10242–10260. doi: 10.3390/molecules190710242. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 118.Li M., Peebles C.A., Shanks J.V., San K.Y. Effect of sodium nitroprusside on growth and terpenoid indole alkaloid production in Catharanthus roseus hairy root cultures. Biotechnol. Prog. 2011;27:625–630. doi: 10.1002/btpr.605. [DOI] [PubMed] [Google Scholar]
- 119.El-Sayed M., Verpoorte R. Catharanthus terpenoid indole alkaloids: biosynthesis and regulation. Phytochem. Rev. 2007;6:277–305. doi: 10.1007/s11101-006-9047-8. [DOI] [Google Scholar]
- 120.Almagro L., Gutierrez J., Pedreño M.A., Sottomayor M. Synergistic and additive influence of cyclodextrins and methyl jasmonate on the expression of the terpenoid indole alkaloid pathway genes and metabolites in Catharanthus roseus cell cultures. Plant Cell Tissue Organ Cult. 2014;119:543–551. doi: 10.1007/s11240-014-0554-9. [DOI] [Google Scholar]
- 121.Liu J., Zhu J., Tang L. Enhancement of vindoline and vinblastine production in suspension-cultured cells of Catharanthus roseus by artemisinic acid elicitation. World J. Microbiol. Biotechnol. 2014;30(1):175–180. doi: 10.1007/s11274-013-1432-z. [DOI] [PubMed] [Google Scholar]
- 122.Kladar N., Srđenović B., Grujić N., Rat M., Gavarić N., Anačkov G., Božin B. St. John’s Wort (Hypericum spp.) - Relation between the biological source and medical properties. In: Howard R.D., editor. Hypericum: Botanical Sources, Medical Properties and Health Effects. Nova Science Publishers; 2015. pp. 53–80. [Google Scholar]
- 123.You M.K., Kim D.W., Jeong K.S., Bang M.A., Kim H.S., Rhuy J., Kim H.A. St. John’s Wort (Hypericum perforatum) stimulates human osteoblastic MG-63 cell proliferation and attenuates trabecular bone loss induced by ovariectomy. Nutr. Res. Pract. 2015;9(5):459–465. doi: 10.4162/nrp.2015.9.5.459. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 124.Nahrstedt A., Butterweck V. Biologically active and other chemical constituents of the herb of Hypericum perforatum L. Pharmacopsychiatry. 1997;30:129–134. doi: 10.1055/s-2007-979533. [DOI] [PubMed] [Google Scholar]
- 125.Greeson J. St. John’s wort (Hypericum perforatum): a review of the current pharmacological, toxicological and clinical literatüre. Psychopharmacology. 2001;153:402–414. doi: 10.1007/s002130000625. [DOI] [PubMed] [Google Scholar]
- 126.Bagdonaite E., Martonfi P., Repcak M., Labokas J. Variation in the contents of pseudohypericin and hypericin in Hypericum perforatum from Lithuania. Biochem. Syst. Ecol. 2010;38:634–640. [Google Scholar]
- 127.Shakya P., Marslin G., Siram K., Beerhues L., Franklin G. Elicitation as a tool to improve the profiles of high-value secondary metabolites and pharmacological properties of Hypericum perforatum. J. Pharm. Pharmacol. 2019;71(1):70–82. doi: 10.1111/jphp.12743. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 128.Gioti E.M., Skalkos D.C., Fiamegos Y.C., Stalikas C.D. Single-drop liquid-phase microextraction for the determination of hypericin, pseudohypericin and hyperforin in biological fluids by high performance liquid chromatography. J. Chromatogr. A. 2005;1093:1–10. doi: 10.1016/j.chroma.2005.07.038. doi: https://doi:10.1016/j.chroma.2005.07.038. [DOI] [PubMed] [Google Scholar]
- 129.Nogueira T.M.J., Marcelo-Curto A., Figueiredo C., Barroso J.G., Pedro L.G., Rubiolo P., Bicchi C. Chemotaxonomy of Hypericum genus from Portugal: geographical distribution and essential oils composition of Hypericum perfoliatum, Hypericum humifusum, Hypericum linarifolium and Hypericum pulchrum. Biochem. Syst. Ecol. 2008;36:40–50. [Google Scholar]
- 130.Zhou L.G., Wu J.Y. Development and application of medicinal plant tissue cultures for production of drugs and herbal medicinals in China. Nat. Prod. Rep. 2006;23:789–810. doi: 10.1039/b610767b. [DOI] [PubMed] [Google Scholar]
- 131.Gadzovska-Simic S. LAP Lambert Academic Publishing; Saarbrucken, Germany: 2010. Secondary Metabolite Production in Cultures in vitro of Hypericum Perforatum L. Effects of Different Exogenous Factors; pp. 1–192. [Google Scholar]
- 132.Kanne H., Burte N.P., Prasanna V., Gujjula R. Extraction and elemental analysis of Coleus forskohlii extract. Pharmacogn. Res. 2015;7:237–241. doi: 10.4103/0974-8490.157966. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 133.Mastan A., Bharadwaj R., Kushwaha R.K., Babu C.S.V. Functional fungal endophytes in Coleus forskohlii regulate labdane diterpene biosynthesis for elevated forskolin accumulation in roots. Microb. Ecol. 2019;78:914–926. doi: 10.1007/s00248-019-01376-w. [DOI] [PubMed] [Google Scholar]
- 134.Bhowal M., Mehta D.M. Coleus forskholii: phytochemical and pharmacological profile. Int. J. Pharm. Sci. Res. 2017;8:3599–3618. [Google Scholar]
- 135.Srinivas Reddy Ch, Praveena Ch, Veeresham C. Approaches to enhance the production of Forskolin in cell cultures of Coleus forskohlii Briq. Int. J. Pharm. Sci. 2011;3:1434–1442. [Google Scholar]
- 136.Patil R.A., Lenka S.K., Normanly J., Walker E.L., Roberts S.C. Methyl jasmonate represses growth and affects cell cycle progression in cultured Taxus cells. Plant Cell Rep. 2014;33:1479–1492. doi: 10.1007/s00299-014-1632-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 137.Löwe J., Li H., Downing K.H., Nogales E. Refined structure of alpha beta-tubulin at 3.5 A resolution. J. Mol. Biol. 2001;313:1045–1057. doi: 10.1006/jmbi.2001.5077. [DOI] [PubMed] [Google Scholar]
- 138.Jordan A., Hadfield J.A., Lawrence N.J., McGown A.T. Tubulin as a target for anticancer drugs: Agents which interact with the mitotic spindle. Med. Res Rev. 1998;18:259–296. doi: 10.1002/(sici)1098-1128(199807)18:4<259::aid-med3>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
- 139.Zhong J.J., Zhu Q.X. Effect of initial phosphate concentration on cell growth and ginsenoside saponin production by suspended cultures of Panax notoginseng. App. Biochem. Biotechnol. 1995;55:241–246. [Google Scholar]
- 140.Malik S., Cusidó R.M., Mirjalili M.H., Moyano E., Palazón J., Bonfill M. Production of the anticancer drug taxol in Taxus baccata suspension cultures: a review. Process Biochem. 2011;46:23–34. doi: 10.1016/j.procbio.2010.09.004. [DOI] [Google Scholar]
- 141.Isah T. Natural sources of taxol. Braz. J. Pharm. Res. 2015;6:214–227. doi: 10.9734/BJPR/2015/16293. [DOI] [Google Scholar]
- 142.Sharma K., Zafar R. Optimization of methyl jasmonate and β-cyclodextrin for enhanced production of taraxerol and taraxasterol in Taraxacum officinale Weber cultures. Plant Physiol. Biochem. 2016;103:24–30. doi: 10.1016/j.plaphy.2016.02.029. [DOI] [PubMed] [Google Scholar]
- 143.Christen A.A., Bland J., Gibson G.M. Cell cultures as a means to produce taxol. Proc. Amer. Assoc. Canc. Res. 1989;30:566. [Google Scholar]
- 144.Zhao C., Song G., Fu C., Dong Y., Xu H., Zhang H., Yu L.J. A systematic approach to expound the variations in taxane production under different dissolved oxygen conditions in Taxus chinensis cells. Plant Cell Rep. 2016;35:541–559. doi: 10.1007/s00299-015-1902-x. [DOI] [PubMed] [Google Scholar]
- 145.Kim B.J., Gibson D.M., Shuler M.L. Relationship of viability and apoptosis to taxol production in Taxus sp. suspension cultures elicited with methyl jasmonate. Biotechnol. Prog. 2005;21:700–707. doi: 10.1021/bp050016z. [DOI] [PubMed] [Google Scholar]
- 146.Isah T., Mujib A. Camptothecin from Nothapodytes nimmoniana: review on biotechnology applications. Acta Physiol. Plant. 2015;37:106. doi: 10.1007/s11738-015-1854-3. [DOI] [Google Scholar]
- 147.Khadke S., Kuvalekar A. Direct somatic embryogenesis and plant regeneration from leaf and stem explants of N. foetida: acritically endangered plant species. Intl. J. Plant An. Envi. Sci. 2013;3(1):257–264. [Google Scholar]
- 148.Govindachari T.R., Viswanathan N. Alkaloids of Mappia foetida. Phytochemistry. 1972;11:3529–3531. [Google Scholar]
- 149.Namdeo A.G., Sharma A. HPLC analysis of camptothecin content in various parts of Nothapodytes foetida collected on different periods. Asian Pac. J. Trop. Biomed . 2012;2(5):389–393. doi: 10.1016/S2221-1691(12)60062-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 150.Patwardhan A. The rufford small grants foundation; UK: 2006. Domestication of Nothapodytes nimmoniana (grah.) Mabb. An Endangered Medicinal Tree from Western Ghats of India; pp. 7–15. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.